95
How Can T-cell-based Vaccines Protect against SIV and HIV?
Mario Roederer
Vaccine Res Ctr, NIAID, NIH, Bethesda, MD, US
Background: Acute infection by simian immunodeficiency virus (SIV)
causes a massive infection of CD4 memory cells throughout the body, leading
directly to their destruction. Over the first few weeks after infection, as
much as 80% of the CD4 memory compartment is destroyed; this represents a
significant insult to the immune system.
Indeed, the extent of the destruction of the CD4 memory compartment
during this early phase predicts long-term survival. Therefore, protecting
against this destruction is an important goal for prophylactic intervention,
such as vaccination.
Methods: To test this, we vaccinated nonhuman primates with a
variety of vectors encoding SIV genes; these regimens induced either cellular
immune responses or cellular and humoral responses.
Results: Vaccines eliciting antigen-specific CD8 T-cell responses
tempered the destruction of the CD4 memory compartment following challenge with
SIV. The preservation of the memory compartment was evident at the early,
post-acute time point (4 weeks), and persisted for many months. The extent of
preservation was also highly inversely correlated with progression to death.
Conclusions: These findings identify a key mechanism leading to
differential rates of progression to AIDS in infected subjects. In addition,
they point to the critical importance of reducing the cell-associated viral
load during acute infection, through therapeutic or vaccination strategies. Finally,
these studies show that a T-cell-based vaccine against HIV or SIV can have
profound protective effects even in the absence of sterilizing immunity.
|